EPO Patents = 1

Forward Citations = 46

Loading Chart...

5 inventors (with patents filed for the assignee):

Roy Louis Maute (3 out of 10 patents)

Andrew Curtis Kruse (3 out of 11 patents)

Aashish Manglik (3 out of 16 patents)

4. Kenneth S Lin (3 out of 3 patents)

5. Aaron Michael Ring (3 out of 35 patents)

3 patents: Sort by Forward Citations

1. 11407801 - SIRP-gamma polypeptide compositions and treatment of cancer (2022-08-09),

2. 10774125 - SIRP-gamma polypeptide compositions and methods of use (2020-09-15),

3. 9845345 - SIRP polypeptide compositions and methods of use (2017-12-19),

Ab Initio Biotherapeutics, Inc. is a biotechnology company that specializes in the discovery and development of novel antibody-based therapeutics. Leveraging their proprietary technology platform, Ab Initio is dedicated to advancing innovative solutions for a range of diseases, including cancer, autoimmune disorders, and infectious diseases. With a focus on precision medicine and personalized treatment approaches, the company is committed to making a meaningful impact on patient care.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

3 Patents

#1,159 in San Diego, CA

#16,426 in California

#72,030 in US

San Diego, CA, United States of America

Ab Initio Biotherapeutics, Inc.